Scroll to Top

USA Stock Report

Real Time Stocks News

Boston, MA, 04/10/2014  (usastockreport) – From being a newbie on the Pharmaceutical block to becoming top hitter on various investor’s list, Inovio Pharmaceuticals (NYSE:INO) gained its first momentum at an initial stage by getting recognition form the World Vaccine Congress. Inovio operates in the field of making vaccines that are DNA-based. Contrary to other vaccines,...